gip and glp 1 receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes GIP (Gastric Inhibitory Polypeptide) Assay
Description
doi: 10.1056/NEJMoa1411892
Some may remain on therapy
doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
If you have missed a dose of semaglutide (Ozempic and Wegovy) or tirzepatide (Mounjaro and Zepbound), take it within 5 days of the missed dose
Swallow it whole with a small sip of plain water (no more than 120ml)
Imeryuz N, Yegen BC, Bozkurt A, Coskun T, Villanueva-Penacarrillo ML, Ulusoy NB
